Open AccessAssociated mortality risk of atypical antipsychotic medication in individuals with dementia
Author(s) -
Peter Phiri,
Tomas Engelthaler,
Hannah Carr,
Gayathri Delanerolle,
Clive Holmes,
Shanaya Rathod
Publication year - 2022
Publication title -
world journal of psychiatry
Language(s) - English
Resource type - Journals
ISSN - 2220-3206
DOI - 10.5498/wjp.v12.i2.298
Subject(s) - quetiapine , olanzapine , risperidone , medicine , aripiprazole , hazard ratio , antipsychotic , dementia , proportional hazards model , psychiatry , cohort , retrospective cohort study , epidemiology , confidence interval , pediatrics , schizophrenia (object oriented programming) , disease
Antipsychotic medications such as risperidone, olanzapine and aripiprazole are used to treat psychological and behavioural symptoms among dementia patients. Current evidence indicate prescription rates for antipsychotics vary and wider consensus to evaluate clinical epidemiological outcomes is limited.